Knowledge Distillery

Our highlighted selection of recent papers from the scientific press for February 2022

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil,…

Risk and outcomes of COVID-19 in patients with multiple sclerosis

Since the start of the vaccination campaign, the development of COVID-19 has been reported in persons who have received one or both doses of mRNA-1273…

Our highlighted selection of Covid-related Literature Reviews from the scientific press for February 2022.

Renin–angiotensin system blockers and susceptibility to COVID-19: an international, open science, cohort analysis

Predictive factors of smell recovery in a clinical series of 288 COVID-19 patients with olfactory dysfunction

Authors describe mRNA1273-elicited binding and neutralizing antibodies in 33 healthy adults in an ongoing phase 1 trial, 180 days after the second…

Our highlighted selection of miscellaneous Covid-related studies from the scientific press for February 2022

Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine

Guillain-Barré syndrome following ChAdOx1-S/nCoV-19 vaccine

Whether or not people who have been infected SARS-CoV-2 should be vaccinated is unclear. This observational cohort study, the authors enrolled 100…